Noninvasive prenatal testing (NIPT) by maternal plasma DNA sequencing is now clinically available for screening fetal chromosomal aneuploidies; these tests have close to 99% sensitivity.. [subscription required, please click here for the article or here for the GenomeWeb article]
Authors: Suk Hang Cheng, Peiyong Jiang, Kun Sun, Yvonne K.Y. Cheng, K.C. Allen Chan, Tak Y. Leung, Rossa W.K. Chiu, Y.M. Dennis Lo